Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology Inc. (NASDAQ: ALGN) is a prominent global medical device company known for designing and manufacturing the Invisalign® System, the world’s most advanced clear aligner system, iTero™ intraoral scanners, and exocad™ CAD/CAM software. These innovations enable digital orthodontics and restorative dentistry, improving patient outcomes and practice efficiencies for over 261,000 doctor customers worldwide. Since its establishment, Align Technology has treated over 17.6 million patients with Invisalign, driving the evolution of digital dentistry through the Align Digital Platform™.
The company’s flagship product, the Invisalign System, has revolutionized the approach to orthodontic treatment. Utilized in over 90 countries, Invisalign combines proprietary virtual modeling software and rapid mass-manufacturing processes to develop customized aligners for each patient. It's a preferred choice for treating a wide range of malocclusions, from simple to complex cases. The system has gained the trust of over 230,000 Invisalign-trained dentists and orthodontists globally.
Align Technology also offers the iTero intraoral scanner, which uses advanced parallel confocal imaging technology to capture detailed digital impressions of patients' teeth, facilitating accurate treatment plans and enhancing patient communication. Over 85% of Invisalign cases start with digital scans, underscoring the importance of iTero technology in modern dental practices.
In 2024, the company launched the iTero Lumina™, a next-generation intraoral scanner that offers a 3X wider field of capture with a significantly smaller and lighter wand, providing faster, more accurate scans and superior patient comfort. This innovation exemplifies Align's commitment to continuous improvement and leveraging emerging technologies.
Align’s commitment to innovation is further demonstrated by its recent acquisition of Cubicure GmbH, a pioneer in direct 3D printing solutions. This acquisition strengthens Align’s strategic innovation roadmap and enhances its manufacturing capabilities for 3D printed products such as the Invisalign Palatal Expander System. This new system offers a removable, clinically effective alternative to traditional palatal expanders, further solidifying Align’s position at the forefront of digital orthodontics.
The company’s financial health remains robust, with significant investments in R&D aimed at driving future growth. Align continues to support clinical and scientific research worldwide through its annual Research Awards Program, fostering advancements in dental care.
Align Technology maintains a strong market presence, bolstered by strategic partnerships and a broad product portfolio, ensuring its role as a leader in the rapidly evolving dental industry. For more information, visit www.aligntech.com.
Align Technology has extended its multi-year agreement with DECA Dental Group for the Invisalign system through early 2025. This partnership will enhance DECA-affiliated practices' access to Align’s iTero Element 5D imaging systems, which support digital workflows in dentistry. The iTero Element 5D can capture 3D impressions and Near Infrared Images without harmful radiation. Align, a leader in orthodontics, aims to improve patient experiences and outcomes through its digital platform and technologies. This collaboration underscores Align's commitment to innovation in dental care.
Align Technology plans to open its first aligner manufacturing facility in the EMEA region, specifically in Wroclaw, Poland, set to start operations in early 2022. This facility will enhance customer support for over 62,700 trained doctors by improving turnaround and delivery times. The investment aims to address a large market opportunity with over 5 million annual orthodontic case starts in the EMEA region. The new site will create more than 2,500 jobs and is part of Align's strategy to solidify its presence in the region and cater to the growing demand for its Invisalign system.
Align Technology announced support for expanding vaccination access through U.S. dentists. As vaccination efforts ramp up, the company highlights the role of dentists, who already serve 31 million Americans annually, in administering vaccines. Federal policies have enabled dentists to provide COVID-19 vaccinations, suggesting a broader role for dentists in public health. Align emphasizes that utilizing trusted community providers can enhance future vaccination initiatives. This strategy could integrate dentists into routine immunizations, improving public health outcomes.
Align Technology (Nasdaq: ALGN) will report its Q1 2021 financial results on April 28, 2021, post-market close. The financial results will be available at 4:00 p.m. ET on the Company’s Investor Relations website. A conference call will follow at 4:30 p.m. ET to discuss these results, accessible through a dedicated audio webcast. A replay of the call will be available for one month post-event, allowing stakeholders to review the details at their convenience.
Align Technology (Nasdaq: ALGN) has partnered with U.S. Ski & Snowboard, designating the Invisalign brand as the Official Smile of the organization. This multi-year sponsorship will include original content for social media and the U.S. Ski & Snowboard website. Athletes will join the Invisalign Smile Squad, receiving treatment and sharing their experiences online. Notable athletes include Olympic champions Jamie Anderson, Maddie Mastro, Red Gerard, and David Wise, who express enthusiasm for enhancing their smiles through Invisalign.
Align Technology (Nasdaq: ALGN) reported a favorable arbitration outcome, receiving a total of $99.7 million from SDC Entities. This includes a $54.2 million payment already made. The arbitration mandates SDC to pay an additional $45.5 million plus interest of $3,000 per day starting March 13, 2021. CFO John Morici highlighted strong performance in the first quarter, driven by increasing demand for Invisalign Clear Aligners and iTero Systems. Despite this positive momentum, the company remains cautious about potential risks, including market competition and economic conditions affecting consumer behavior.
Align Technology has announced a partnership with the Golden State Warriors, becoming the Official Smile Partner. This collaboration aims to engage Warriors fans through various channels, including TV and digital media, and features jersey sponsorships with the Warriors' G League and esports teams. The partnership emphasizes fan experience and community engagement, reflecting Align’s commitment to enhancing smiles. Align also supports Junior Achievement of Northern California as part of this initiative. The deal is expected to increase brand visibility across multiple platforms.
Align Technology, Inc. (Nasdaq: ALGN) announced its participation in the 2021 SVB Leerink Global Healthcare Conference on February 26, 2021. The presentation will be held virtually from 10:40 A.M. to 11:10 A.M. Eastern Time and will be available for live streaming on their Investor Relations website. An archived version will be accessible for three months post-event. Align Technology specializes in innovative dental solutions, including the Invisalign system, and has treated over 9.6 million patients. For more details, visit www.aligntech.com.
FAQ
What is the current stock price of Align Technology (ALGN)?
What is the market cap of Align Technology (ALGN)?
What is Align Technology's main product?
How many patients have been treated with Invisalign?
What technologies does Align Technology offer?
What is the iTero Lumina™ scanner?
What was the purpose of acquiring Cubicure GmbH?
How does Align Technology support scientific research?
What is the Align Digital Platform?
How many Invisalign-trained doctors are there globally?
What is the financial outlook for Align Technology?
Where can I find more information about Align Technology’s products?
